| Literature DB >> 35625086 |
Zahra Pezeshkian1, Seyed Ziaeddin Mirhoseini1, Shahrokh Ghovvati1, Esmaeil Ebrahimie2,3,4.
Abstract
Feed efficiency is important due to the high cost of food, which accounts for about 70% of the total cost of a turkey breeding system. Native poultry are an important genetic resource in poultry breeding programs. This study aimed to conduct a global transcriptome analysis of native male turkeys which have been phenotyped for high and low feed efficiency. Feed efficiency traits were recorded during the experimental period. After slaughter, the three most efficient and three least efficient male turkeys were selected for RNA-Seq analysis. A total of 365 genes with different expressions in muscle tissue were identified between turkeys with a high feed efficiency compared to turkeys with a low feed efficiency. In the pathway analysis of up-regulated genes, major pathways included the "metabolism of glycine, serine, and threonine"; the "adipocytokine signaling pathway" and the "biosynthesis of amino acids". In the pathway analysis of down-regulated genes, the major pathways included "dorso-ventral axis formation" and "actin cytoskeleton regulation". In addition, gene set enrichment analyses were performed, which showed that high feed efficiency birds exhibit an increased expression of genes related to the biosynthesis of amino acids and low feed efficiency birds an increased expression of genes related to the immune response. Furthermore, functional analysis and protein network interaction analysis revealed that genes including GATM, PSAT1, PSPH, PHGDH, VCAM1, CD44, KRAS, SRC, CAV3, NEDD9, and PTPRQ were key genes for feed efficiency. These key genes may be good potential candidates for biomarkers of feed efficiency in genetic selection in turkeys.Entities:
Keywords: RNA-Seq; Turkey; conversion coefficient; different gene expression analysis; feed efficiency
Year: 2022 PMID: 35625086 PMCID: PMC9138110 DOI: 10.3390/ani12101240
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
The primer sequences of target genes and housekeeping genes used in this study.
| Gene Name | Accession Number | Sequence of Primers (5′ → 3′) * | Product Length (bp) | |
|---|---|---|---|---|
| GATM | XM_019619468 | Forward | CGTTTAATATCATTGGACCTGG | 216 |
| Reverse | TTGAAGTCTCATTGGCATCG | |||
| GNMT | XM_010706618 | Forward | CTGGAGCAGGACCTGGAGAAG | 246 |
| Reverse | CTTGGTCAGGTCGCTCTTGTAG | |||
| KRAS | NM_001303223 | Forward | CTGAAGATGTCCCAATGGTGCT | 182 |
| Reverse | GTGTTTTCTGATTCTCGAACTAATG | |||
| MAT1A | XM_003207784 | Forward | ATGCCAAAGTTGCTTGTGAGAC | 192 |
| Reverse | GTGATTGCTGTTCCAGTGCCA | |||
| CAV3 | XM_003210208 | Forward | CAAAGCGGATCAACGAAGAC | 200 |
| Reverse | GATGAGGGCGAAGAGGAAGC | |||
| MYOZ2 | XM_003205713 | Forward | CACAACGAAACAGTACGCAAGG | 196 |
| Reverse | TGGGTGAGACTCAATACAATGAG | |||
| MUSK | XM_010726142 | Forward | GAATATAACCAGGACTTGCTACAG | 164 |
| Reverse | CAGTAATTCTCAGCATCAGACAG | |||
| SMTN | XM_010720500 | Forward | GACAGGCAGCATCTTTGACC | 135 |
| Reverse | CTGTGAGGTTGATGTCTTGGG | |||
| MAP2K6 | XM_010721466 | Forward | TTTAGCAACCGAGTCAACGA | 105 |
| Reverse | TTTAGCAACCGAGTCAACGA | |||
| ALG6 | XM_003208901 | Forward | CAAGAAGGGACTGAAAGGAAAGG | 169 |
| Reverse | CTACTTTATCCTCAAACAAGCCTC | |||
| MTHFD2 | XM_003206271 | Forward | TCATAAAGAGAACAGGCATCCCA | 154 |
| Reverse | TAACGGTGTGATATTGTGACTGTG | |||
| CD36 | XM_010726962 | Forward | CCAGGAAGCTCTGTTTACAGG | 121 |
| Reverse | TATCGCACCCTATATGTGTAAGGT | |||
| APP | XM_010722443 | Forward | GAAGTTGTCAGAGTCCCTACC | 173 |
| Reverse | TTCTGCCTCCTCCCATTCTC | |||
| AGO2 | XM_031552935 | Forward | TGGAAGAGATAAAGTGGAGTGGA | 156 |
| Reverse | CTGGATGGTTTCAAATGGGAC | |||
| ACAT2 | XM_003204090 | Forward | AGGAAAGCTATTGACAAAGCCA | 186 |
| Reverse | CAAGGATGCGACAACCAGAG | |||
| DLL1 | XM_031552428 | Forward | CTTGTGCTAATGGAGCCCAG | 196 |
| Reverse | GCAGTTCTTCCCGTTGTATCC | |||
| WIPI1 | XM_010721504 | Forward | CAGGTTATTCGGAGGATGGT | 118 |
| Reverse | ACGGCACAAGATTATAGGAGGA | |||
| ASNS | XM_019616348 | Forward | ATATTTCCATAAGGCACCATCTCC | 159 |
| Reverse | GTAAGAAGTAAGCGATGATCCAG | |||
| SRC | XM_003211956 | Forward | CAGCAAGAGCAAACCCAAAGA | 103 |
| Reverse | CTTGTTGGGGGTCTGCGAG | |||
| EIF2AK3 | XM_010710584 | Forward | GAGTCAAGACCCTGAGCGATGT | 178 |
| Reverse | GGTTTGGCTGGGAGTTCCA | |||
| 18S | AJ419877 | Forward | CTGCCCTATCAACTTTCGATGG | 171 |
| Reverse | GGATGTGGTAGCCGTTTCTCA | |||
| GAPDH | NM_001303179 | Forward | CCCAGAACATCATCCCAGCAT | 137 |
| Reverse | ACGGCAGGTCAGGTCAACAAC | |||
| RPS7 | NM_001285787 | Forward | TGAAGTAGGTGGTGGCAGGAA | 165 |
| Reverse | CTCGTTGGCTTGGGCAGAA |
* All primers were designed specifically for the current study.
A summary of short reads before and after trimming and mapped reads which were aligned against the reference genome for HFE and LFE turkeys.
| Sample | Raw Reads | Trimmed Reads | Mapped Ratio (%) |
|---|---|---|---|
| H1 | 71,407,390 | 71,397,082 | 74.56 |
| H2 | 81,000,062 | 80,986,086 | 72.76 |
| H3 | 80,467,686 | 80,451,478 | 74.25 |
| L1 | 93,253,472 | 93,235,602 | 74.56 |
| L2 | 75,960,342 | 75,946,338 | 73.1 |
| L3 | 69,196,190 | 69,186,026 | 74.63 |
Figure 1Classification of HFE and LFE turkeys according to the results of multiple corresponding analyses. The results show that HFE and LFE turkeys can be divided into two groups.
Figure 2The volcano plot indicates the −log10 (p-value) for genome-wide genes (y-axis) plotted against their respective log2 (fold change) (x-axis). Red dots represent up-regulated genes and green dots represent down-regulated genes.
Figure 3Gene ontology analysis of all DEGs. The bubble plot shows the GO enrichment of differentially expressed genes in five biological process terms and one molecular function.
Pathway analysis of DEGs in HFE compared to LFE turkeys (genes with red font color represent up-regulated genes, and genes with green font color represent down-regulated genes).
| Term | Biological Process | Count | Genes | |
|---|---|---|---|---|
| Up-regulated | ||||
| mgp00260 | Glycine, serine, and threonine metabolism | 6 | 1.64 × 10−5 |
|
| mgp01230 | Biosynthesis of amino acids | 5 | 0.001 |
|
| mgp04920 | Adipocytokine signaling pathway | 5 | 0.0022 |
|
| mgp01100 | Metabolic pathways | 17 | 0.021 |
|
| Down-regulated | ||||
| mgp04320 | Dorso-ventral axis formation | 4 | 0.002 |
|
| mgp04810 | Regulation of actin cytoskeleton | 7 | 0.022 |
|
Ontology analysis of up-regulated genes in HFE compared to LFE turkeys.
| Term | Biological Process | Count | Genes | |
|---|---|---|---|---|
| GO:0006564 | L-serine biosynthetic process | 3 | 3.09 × 10−4 | |
| GO:0009298 | GDP-mannose biosynthetic process | 2 | 0.03 | |
| GO:0048630 | skeletal muscle tissue growth | 2 | 0.03 | |
| GO:1990000 | amyloid fibril formation | 2 | 0.03 | |
| GO:0034383 | low-density lipoprotein particle clearance | 2 | 0.03 | |
| GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 2 | 0.03 | |
| GO:0051289 | protein homotetramerization | 3 | 0.033 | |
| GO:0010459 | negative regulation of heart rate | 2 | 0.04 | |
| Cellular component | ||||
| GO:0005615 | extracellular space | 9 | 0.033 | |
| GO:0033017 | sarcoplasmic reticulum membrane | 2 | 0.039 | |
| GO:0070062 | extracellular exosome | 21 | 0.046 | |
| GO:0030018 | Z disc | 3 | 0.0498 | |
| Molecular function | ||||
| GO:0004615 | phosphomannomutase activity | 2 | 0.02 | |
Ontology analysis of down-regulated genes in HFE compared to LFE turkeys.
| Term | Biological Process | Count | Genes | |
|---|---|---|---|---|
| GO:0035914 | skeletal muscle cell differentiation | 6 | 4.41× 10−5 | |
| GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 5 | 0.003 | |
| GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3 | 0.0083 | |
| GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 10 | 0.0086 | |
| GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 12 | 0.0106 | |
| GO:0048536 | spleen development | 3 | 0.0252 | |
| GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 5 | 0.0273 | |
| GO:0048008 | platelet-derived growth factor receptor signaling pathway | 3 | 0.0287 | |
| GO:0009791 | post-embryonic development | 4 | 0.03 | |
| GO:0030968 | endoplasmic reticulum unfolded protein response | 3 | 0.04 | |
| GO:0048705 | skeletal system morphogenesis | 3 | 0.049 | |
| Term | Cellular Component | |||
| GO:0005634 | Nucleus | 31 | 0.001 | |
| GO:0005667 | transcription factor complex | 7 | 0.0025 | |
| GO:0005730 | Nucleolus | 13 | 0.013 | |
| Term | Molecular function | |||
| GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding | 7 | 9.69E-05 | |
| GO:0043565 | sequence-specific DNA binding | 8 | 0.0059 | |
| GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 8 | 0.009 | |
| GO:0003713 | transcription coactivator activity | 6 | 0.01 | |
| GO:0008270 | zinc ion binding | 18 | 0.02 | |
| GO:0046872 | metal ion binding | 13 | 0.028 | |
| GO:0003700 | transcription factor activity, sequence-specific DNA binding | 7 | 0.035 | |
Figure 4Comparing hub genes that were identified using four centrality algorithms of CytoHubba. (A) MCC, (B) degree, (C) closeness, (D) MNC.
Figure 5Venn plot to identify significant hub genes created by four centrality algorithms. Areas with different colors are related to different methods. The cross areas show the common DEGs. There are seven genes in concurrent areas.
Figure 6The significant modules of the DEGs PPI network. (A–F): Modules 1–6. (red nodes: up-regulated genes, green nodes: down-regulated genes). (G): Functional enrichment analysis of module 1. The two green spectra represent two different gene ontologies in which the genes of this module are involved (L-serine biosynthetic process and alpha-amino acid biosynthetic process).
List of all gene sets with an FDR ≤ 0.25.
| KEGG Set | SIZE | NES | FDR Q-Value | Higher Expression | |
|---|---|---|---|---|---|
| KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM | 20 | 1.66 | 0 | 0.194 | HFE |
| KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 33 | −1.85395 | 0 | 0.046 | LFE |
| KEGG_JAK_STAT_SIGNALING_PATHWAY | 70 | −1.51451 | 0 | 0.188488 | LFE |
| KEGG_DORSO_VENTRAL_AXIS_FORMATION | 15 | −1.46771 | 0 | 0.19519 | LFE |
| KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY | 30 | −1.42309 | 0 | 0.200888 | LFE |
| KEGG_WNT_SIGNALING_PATHWAY | 96 | −1.4685 | 0 | 0.202649 | LFE |
| KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 54 | −1.43289 | 0 | 0.205478 | LFE |
| KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 92 | −1.4886 | 0 | 0.205977 | LFE |
| KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 57 | −1.48398 | 0 | 0.206473 | LFE |
| KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 49 | −1.49622 | 0 | 0.210286 | LFE |
| KEGG_MAPK_SIGNALING_PATHWAY | 163 | −1.51628 | 0 | 0.212236 | LFE |
| KEGG_HEDGEHOG_SIGNALING_PATHWAY | 33 | −1.44312 | 0 | 0.215766 | LFE |
| KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 51 | −1.52378 | 0 | 0.238885 | LFE |
| KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY | 48 | −1.51919 | 0 | 0.241404 | LFE |
| KEGG_GNRH_SIGNALING_PATHWAY | 61 | −1.38625 | 0 | 0.246314 | LFE |
Figure 7Gene set enrichment analysis (GSEA). The enrichment plot of most significant expressed in (A) HFE (glycine, serine, and threonine metabolism) and (B) LFE (RIG-I-like receptor signaling pathway) birds.
Figure 8Expression stability analysis of reference genes in breast muscle tissue of turkeys. The most stably expressed genes have lower M values.
Figure 9The results of qRT-PCR confirmation for 20 selected differentially expressed genes. The X-axis shows 20 selected genes for qRT-PCR assays, and the Y-axis demonstrates the log2 (fold change) derived from RNA-Seq and qRT-PCR.
Figure 10Quantitative real-time PCR (qRT-PCR) validation and linear regression analysis of RNA sequencing of selected DEGs.
Figure 11Three important pathways which were significant in HFE turkeys, including glycine, serine, and threonine metabolism, the adipocytokine signaling pathway, and the biosynthesis of amino acids (created with BioRender.com, accessed on 10 April 2022).